Women's Refusal to Participate in a Randomized Trial Involving First-trimester Screening for Pre-eclampsia: Factors Associated With Refusal and Reasons for Acceptance and Refusal
NCT ID: NCT06322771
Last Updated: 2025-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
472 participants
OBSERVATIONAL
2024-04-11
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Women's Perspective on First-trimester Preeclampsia Screening
NCT05123560
Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination
NCT06968117
What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE
NCT03668184
Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
NCT06059937
Unravelling the Interplay of Weight Stigma and Pregnancy Outcomes: A Prospective Cohort Study
NCT06531694
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Comparison of demographic characteristics between the two groups
* Group 1: women accepting to participate in RCT
* Group 2: women refusing to participate in RCT
3. Assessment of motivations for acceptance (based on questionnaire given to women who agree to participate)
4. Evaluation of reasons for refusal to participate - obstacles (based on the questionnaire given to women who refuse to participate).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Refusal
A questionnaire will be given to patients who have refused to participate in the RANSPRE trial
Questionnaire
Questionnaire about refusal
Acceptance
A questionnaire will be given to patients who have agreed to participate in the RANSPRE trial
Questionnaire
Questionnaire about acceptance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Questionnaire about acceptance
Questionnaire
Questionnaire about refusal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* monofetal pregnancy
* between 11 and 14 weeks
* legal age
* health insurance coverage
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yoann Athiel, MD
Role: PRINCIPAL_INVESTIGATOR
Port-Royal Maternity - APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Port-Royal Maternity
Paris, IDF, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP240376
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.